ClinicalTrials.Veeva

Menu

Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy

U

Université de Sousse

Status

Completed

Conditions

Urologic Neoplasms

Treatments

Procedure: Antegrade double-J stent

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Ureteral double- J stent is usually inserted by retrograde approach for the treatment of obstructed upper urinary tract. The antegrade approach, can a suitable alternative in certain situations without the need for general or spinal anesthesia. The present study demonstrates the indications, success rate, and complications of this approach in the treatment of malignant obstructive uropathy.

Full description

Data of consecutive patients in whom antegrade ureteral stent¬ing was performed between January 2013 and February 2020 were retrospectively analysed using patient records and radiology reports. A total of 174 patients (sexe ratio = 0.51, age range 9-91 years; mean age, 54 years) were included in the study.

Ureteral obstruction was caused by bladder cancer (n=92), uterin cancer (n=31), prostate cancer (n=28), colorectal cancer (n= 15) and retroperitoneal tumor (n= 8) (Table 1).

Enrollment

174 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • malignant uropathy obstruction

Exclusion criteria

  • benign uropathy obstruction

Trial design

174 participants in 1 patient group

malignant uropathy
Description:
Antegrade double-J stent
Treatment:
Procedure: Antegrade double-J stent

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems